The Neuroscience of Interpersonal Connectivity:
Benchmarking Strategies for Effective Interventions
Dr Pieter Rossouw
School of Psychology
The University of Queensland
The functioning of the human brain
Our treatment of the human condition can be thought of as the direct correlation of how well we understand the functioning of the human brain—in other words, how we see wellness, and its counterpart psychopathology, directly depends on our view of the brain.
For many years the brain was viewed as an electrical system, a system that transfers electrical signals from key neural areas to other neural areas. Since Julius Bernstein identified the electrical properties of the brain’s cells—their resting and action potentials, how electrical signals activate communication between one brain cell and another—a host of researchers have focused on numerous aspects of this signalling process, and explored the implications of this in terms of wellness and un-wellness (pathology), all related to neural signalling. Many of these researchers have been honoured with Nobel prizes in medical science.
The theory of the brain as an electrical centre directed neuroscience research for almost a hundred years, throughout the latter half of the 19th century and the first half of the 20thcentury. During this period, treatments for neural dysfunctions focused predominantly on various forms of electrical modalities, with electroconvulsive therapies dominating. Although neuroscience has since developed rather more sophisticated theories towards understanding the development and actions of the brain and the pathogenesis of psychopathology, the earlier theory still contributes greatly to what we know of the functioning of the human brain today, and is a significant role player in the debate towards maximizing outcomes in the treatment of mental disorders.
A new paradigm in neuroscience emerged when researchers, the pharmacologist and Nobel laureate Henry Dale being one of the first, demonstrated that the activation of action and synaptic potentials is the result of not an electrical but a chemical release—specifically, the release of acetylcholine, which sets the electrical process in motion. The implications of this discovery were significant; and subsequently the role of neurochemicals in the neural communication process became a major focus of research. Following the ground-breaking work of Dale and others, including the Australian neurophysiologist and Nobel laureate John Eccles and his colleagues, a major paradigm shift in neuroscience occurred. The focus changed to understanding the effect of chemicals on the brain. The findings—that to change the activation of a single neurochemical causes significant changes to occur in the brain—were astounding. The implications were equally profound, for if we could manipulate the chemical balance, we should be able to change mood and behaviour— and the course of psychopathology. We witnessed the dawn of the medical model: people no longer studied to become a doctor; they were studying medicine! Research focused on compounds to address chemical “imbalances”. More and more neurochemicals were discovered (LeDoux 2003). The interplay between chemicals, how to excite or inhibit these chemicals, and how to provide guidelines to maximise outcomes, was explored. Treating people became about assessments that would enable doctors to administer the correct medicine. And, finally, as pharmaceutical companies identified the need for chemical products to treat the full spectrum of psychopathological disorders, research into the effect of chemical compounds exploded.
At this time, psychotherapy—the so called talking therapies and behavioural interventions—were viewed as allied health modalities. These approaches were seen as feel good add-ons to the real work, which was the assessment of neurochemical disorders, the introduction of chemical compounds, and the monitoring of change and side-effect profiles.
One particular psychotherapeutic approach stemmed the tide, however, and aligned itself very closely to the medical model. This approach, called Cognitive Behavioural Therapy (CBT), was developed by A. T. Beck and colleagues at the University of Pennsylvania (cf., Beck & Alford, 2009). Their theory was that the origin of mental dysfunction stems from childhood experiences that ultimately develop into irrational belief systems: These belief systems can best be treated by activating cognitive processes to challenge the irrational beliefs. It is interesting to note that—although no neural research was done for many years to test these theories—an unparalleled stream of research demonstrated the benefits of CBT (generally in conjunction with neurochemicals) to facilitate change for clients suffering from various psychopathologies. A gold standard was set: The treatment of mental disorders assumed the latest chemical compounds (those with the lowest side-effect profile) and, when indicated, Cognitive Behaviour Therapy (Beck & Alford, 2009). Definitive descriptors like “best practice” were often linked to the marriage of chemical interventions in combination with CBT. However, chemical intervention always took precedence; and in some cases—especially the more severe pathologies such as schizophrenia, psychosis, intellectual disabilities, other forms of dissociation, and some of the spectrum disorders—the gold standard remained medication alone.
The focus on cognitive neuroscience, and especially the focus on cognitive therapies, is in many respects a recent development of the same paradigm, although it may be said that cognitive neuroscience has also, to some extent, embraced the newer development of neuroscience, signalling a shift from the neurochemical model.
A new frontier in understanding the brain
The 1990s, the decade of the brain, hailed a new understanding of neural development, wellness and pathology: the early pioneers, Eric Kandel, Joseph LeDoux, Wayne Drevets, Bessel Vander Kolk, Dust Ongar, Michael Merzenich, and others, pointed towards a new appraisal of neural functioning. The new science of the brain pointed beyond the electrical systems and chemical systems towards viewing the brain as a communication agent, a social entity that operates in line with its genetic makeup and in response to its environment. The future understanding of the brain, its complex systems and responses to the environment, instead points back to Freud who, in 1884, had suggested that the unconscious is located in synaptic space. Although it is much more complex than this, Freud was basically correct: The brain, whose cells die as soon as they are isolated, is a social entity that cannot survive on its own.
In 1998, Kandel predicted that by talking to patients, clinicians could not only make their patients think, feel or behave differently, they could also physically alter the hardware of the brain (Kandel 1998). The brain is more than an electrical system or a chemical soup, it is a network of connections set up in a way, first and foremost, to survive and, secondly, to thrive and proliferate. Hence, in order to ensure survival and maximize outcomes, our brains connect and fire in specific ways, and even wire in specific ways, so that ultimately we become who we are. This is the process of genetic expression.
New studies in neuroscience demonstrate that psychological disorders are complex disorders with complex pathogenesis. We are only at the early stages of understanding the complex interactions of genetics, environmental input, electrical activity, neuromodulator activity, neurochemical activity, the neural structures and pathways of the brain, and epigenetics—gene expression as a result of a person’s interactions with the environment.
The new research also illustrates the complexities of neural networks and difficulties in the quest to understand memory systems, which are the basis of pathology. As meta-analysis studies are now showing, any attempt to manage psychological disorders with simple bio-electrical or chemical interventions is bound to have very limited effects (Gallanti, 2003).
It is now well recognised that the brain cannot survive in total isolation—its entire neural makeup requires ongoing interaction with the environment. One of the most profound expressions of the brain’s interdependence with its environment is the mirror neuron system (Rossouw, 2013a); in fact, leading neuroscientists have suggested that we learn everything—from basic language responses to moral decisions—through the mirror neuron system (Rizolatti et al., 2004). Not only does the brain process information and respond as result of the interplay with its environment, it also adjusts itself and changes as a result of such interaction. This principle of neural plasticity is clearly demonstrated in the study of epigenetics involving neural chemistry—that is, combining the neural circuitry and the neural genetic expression (Kilner et al., 2007). A brain that is exposed to an enriched, healthy environment will flourish and develop strong neural networks; thereby, in the process, it will enhance its capacity and resilience when it encounters conditions that compromise or threaten its wellness. Conversely, a brain that is exposed to adverse conditions becomes significantly compromised, and its genetic risks are more profoundly expressed, resulting in an increasing inability to manage life’s challenges. In this view, mental illness is an illness of neural networks—an illness of neural connections and not just a dysfunction of neurochemical activation or inhibition (Kandel, 2001, 2006; Kandel et al., 2013).
The implications of these studies are profound: they suggest quite strongly that the role of chemical interventions to address mental illness is significant but limited. Mental illness is the neural result of the interplay between genetic make-up, genetic expression, early life experiences, ongoing experiences, and the capacity for resilience, that is, the neural capacity to respond to internal and external cues (Kandel, 2006). While neurochemical responses to cues are significant, managing neurochemicals is only a small part of managing mental illness. Instead, to effectively address mental illness, neural pathways need to shift. The brain’s ability to change has been demonstrated by enriched environments—of which talking therapies are an important part. In other words—or, to put it simply—neurochemical interventions cannot alter neural pathways or facilitate the construction of new neural pathways.
So, first of all, what are the benefits of introducing chemicals to manage mental illness? Clearly, the main benefit is to alter chemical activation and inhibition. Let us consider two examples. One of the significant symptoms of many mental illness is agitation—that is, the inability to “down-regulate” or calm down. As a result, compounds that activate the GABA response (the release of neurochemical gamma-aminobutyric acid) have been very popular. The group of compounds that seem to have the best effect on activating GABA release is the benzodiazepines whose ability to enhance symptom relief is very quick and effective. For a long time it has been standard practice to prescribe benzodiazepines for a myriad of conditions, including many types of mental illness, and only fairly recently have the detrimental effects of long-term benzodiazepine intake on neural systems been demonstrated. In the first place, it induces a pattern of dependence as the effect wears off, resulting in the need to increase the dosage; and, in the second place, it enhances closed neural activation resulting in: decreasing neural sprouting, inhibiting neural plasticity and neuro-genesis caused by slowing down the production of the growth hormone BDNF (brain-derived neurotrophic factor), and increasing the risk of neuro-degenerative disorders—Alzheimer’s and dementia among them.
The effects of other chemical inhibitors, such as the compounds that inhibit the re-uptake of serotonin (SSRI), are well known. These compounds manage the re-uptake process of serotonin release and enhance the flow of serotonin to the frontal neural regions, with the result that mood seems to be better regulated, and the frontal cortical systems—which are involved in problem solving and executive functioning—are better informed. Many research studies have demonstrated the benefits of SSRI intake to enhance wellness, especially conditions like mood and anxiety disorders. However, recent studies in molecular neuroscience have demonstrated that the long-term intake of SSRIs may not be nearly as safe as suggested—rather, that the effect of the long-term use of SSRIs on neuro-molecular levels is profound. P. W. Andrews and colleagues have recently demonstrated how long-term intake of SSRIs changes the morphological structure of neurons, causing apoptosis (the death of neurons), thus increasing the risk of relapse due to the long-term intake of the very substance that was meant to address the illness in the first instance—in other words, producing a downward spiral of deterioration in the condition (Andrews, Thomson, Amstadter, & Neale, 2012).
There is, therefore, ample reason to argue that the neural research showing the working of the brain as a neural network, and not an electro-chemical process, may well signal the end of the medical model in the treatment of mental illness (Rossouw 2011; Rossouw 2013b). The days when a chemical intervention (medication) is regarded as the first line and often primary intervention to treat mental disorders, and when enriched environments—involving interventions such as psychotherapy, enhancing social wellness, quality sleep, exercise and good nutrition—are seen as auxiliary, are numbered. The reverse is the likely scenario in light of modern neuroscience indicators.
The art and science of therapy
Cutting edge neuroscience research, which often includes imaging procedures, has demonstrated how the construction of effective new neural pathways can be facilitated through the introduction of enriched environments (LeDoux 2003). An enriched environment is an environment where the brain can flourish, and stress is effectively managed. The opposite of an enriched environment is the presence of a threatening environment, one that results in a violation of survival responses, leading to changes of stress-related neurochemicals and the consequent strengthening of survival communication patterns—wiring a neural system that has to survive in a compromised environment. Once this compromised neural wiring is set, neurochemical interventions will only offer short-term symptom relief (Cozolino, 2010). Thus, in order to address the condition properly, the neural patterns themselves need to be addressed—and this can only occur in an enriched environment. Further, the facilitation of an enriched environment requires conditions that specifically encourage effective neural firing rather than protective (survival-based) neural activation. The core conditions are:
- The need for safety; and
- The need for control.
In his work over time with sea slugs, Aplysia californica, Eric Kandel showed how the environment can shape and change the neural connections of very simple organisms. Clearly, this is much more the case in the highest order organism—the human brain—where physical and emotional safety will down-regulate stress chemicals, and stress signalling, and shift protective neural patterns to enhance open neural proliferation. This is the basis of wellness. The fascinating work on neural plasticity by the renowned psychiatrist and neuroscientist, George Bach-Y Rita, demonstrated the need for safety and control to facilitate effective neural growth and recovery from trauma (Bach-y-Rita, 1972; Springer & Deutsch, 1999). The implications for psychotherapy are clear: There is an art in the science of facilitating the safety to enhance neural activation and effective neural communication to the executive regions. Imaging studies have shown changes to neural networks as a result of talking therapies—and these strategies are now refined and enhanced to the extent that they can facilitate effective permanent changes. Key indicators are that effective psychotherapy requires a bottom-up approach to be in line with the neural activation, the need for down-regulation of stress patterns, and the neural principle of cortical blood flow and distress responses (Rossouw, 2012).
The introduction of interpersonal neurobiology by prominent researchers, Daniel Siegel, Louis Cozolino, Allan Schore and others, through the Norton publication series, provides significant direction in the understanding of the neural correlates of wellness, and the role of talking therapies to facilitate neural change (Schore, 2012; Siegel, 2010, 2012). Current studies at the University of Queensland, which are focusing on MRI, fMRI, neurochemical and PET studies to measure the effect of a number of psychotherapeutic interventions on neural patterns, neural connections and neural structures will facilitate the introduction of global programs that contribute to the effective treatment of unwellness. Too many strategies are suggested as a result of short-term studies without clear indictors of their long-term efficacy or risk of relapse.
The brain as neural network
The Canadian psychologist Donald Hebb identified an essential principle of neuroscience (Hebb, 1949). He suggested that neural firing happens in a consistent sequence to such an extent that it can be predicted: The probability of consistency of neural firing was later popularized by the phrase “neurons that fire together wire together”. This principle has significant implications for therapy, especially when linked with two other key findings—the role of mirror neurons (Iacoboni, 2008; Rizolatti et al., 2004; Rossouw, 2013), and the principle described by Merzenich that “neurons that fire apart, wire apart” (Kandel, 2006). These principles, alongside the concept of mirror neurons, form the foundations of the current paradigm of the social brain. The enmeshment of nature and nurture continues to develop and inform the neural networks: The brain’s connection to and interaction with its environment, therefore, as well as the impact of the environment itself, not only inform neural responses but also mould the network, both in response to, and as a result of, that environment. The mirror neuron system, described by the renowned neuroscientist V. S. Ramachandran as the DNA of neuroscience (Oberman & Ramachandran, 2008), demonstrates the brain’s ability to constantly adjust and change throughout its neural network. These changes are very clear when basic needs are compromised, or (worse) violated, resulting in major changes in neurochemical releases, which are eventually visible on a neurostructural level as systems of survival responses that change the neural pathways on a permanent level. Since the ground-breaking studies by Shen and Battersby and colleagues (Shen et al., 2000), which demonstrated that genetic risk is never expressed in enriched environments, many studies have demonstrated how the brain can change its network structure through enriched environments. Talking therapies are identified as facilitators of enriched environments.
The science of the art of therapy
The role of talking therapies in changing neural connectivity and reshaping higher neural connections is indeed in line with Eric Kandel’s prediction, which heralded the dawn of a “remarkable scientific revolution” that would change the paradigm for understanding the brain and, indeed, psychotherapy for the 21st century (Kandel, 1998). No longer can managing the brain or mental disorders, its thoughts, emotions and behaviour, be seen as a mechanical process where following a set of set of protocols will facilitate effective long-term neural change. The science of therapy is indeed imbedded in interpersonal connectivity—the science is in the “art” of interpersonal neural connectivity. Even when we use mechanical tools such as internet-based interventions, their efficacy is based on the neural principles that foster the belief that they were developed by a compassionate person that has the person’s best interests at heart. This down-regulates the fear response and up-regulates the ability to change. The efficacy of interventions in the years to come will be measured by assessing changes in neural networks rather that short-term self-reports.
The “science of the art of therapy” is taking us back to the future as the essential role of interpersonal relationships demonstrate the basis of the brain’s ability to change, where the absence thereof demonstrates the basis of neural pathology. This has been shown to be true for the most basic neural organisms, aplysia californica, and the highest primates—ultimately, the human brain. Psychotherapies have more in common and essentially are not very different—they all build on the basic principles of interpersonal connectivity to enhance outcomes. This is the essence of enriched environments. At a neural level there is often little difference between approaches, and claims of “what works” are often overrated if key basic principles are not acknowledged. Current neuroscience research on neural networks points towards key aspects to facilitate wellness, especially for higher order disorders such as depression and anxiety, which have an unclear pathogenesis. These disorders are much more complex than a single inhibitor of a specific neurotransmitter (e.g., SSRIs) or GABA activation to enhance the relaxation response, can address successfully. These disorders are much more complex than can be addressed by merely changing unhelpful thought patterns or managing some unhelpful moods or behaviours.
The science of the art of therapy is more than a strict set of selection criteria for a manualised research focus to ensure good research outcomes—this would run the risk of facilitating short term change for the worried-well) (Rossouw 2013c). The science of the art of therapy is adherence to the principles of neural communication: the connection between right brain to right brain (Rossouw, 2012), the facilitation of safety, the therapeutic attachment, the down-regulation of distress activation and neurochemicals, the introduction of small shifts in neural firing (the concept of controlled incongruence), the management of on-going activation of new neural communication, and, ultimately, the facilitation of new neural networks—a brain that changes itself.
Identifying strategies to facilitate these changes is the ongoing challenge of the science and the art of psychotherapy. These strategies need to be considered in light of Kandel’s Third Law:
Patient care is our most important responsibility. That is why we are here. Never let patient care take a secondary role. Patient welfare is the ultimate goal of biological science and it is the engine that drives the whole scientific enterprise.
Neuroscience opens amazing new opportunities to benefit your clients—utilise it, do it justice and enjoy the future! (Kandel, 2005).
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author.
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012). Primum non nocere: An evolutionary analysis of whether antidepressants do more harm than good. Frontiers in Psychology, 3, 1-19. doi: 10.3389/fpsyg.2012.00117
Bach-y-Rita, P. (1972). Brain mechanisms in sensory substitution. New York, NY: Academic Press.
Beck, A. T., & Alford, B. A. (2009). Depression: Causes and treatment. Philadelphia, University of Pennsylvania Press.
Cozolino, L. (2010). The neuroscience of psychotherapy: Healing the social brain. New York, NY: Norton.
Gallati, D. (2003). Metaanalyse über die Erfolgsmessung in Vergleichsstudien von Depressionsbehandlungen [Meta-analysis of outcomes in comparative studies of depression treatments]. Unpublished master’s thesis, Institut für Psychologie, Universität Bern, Switzerland.
Hebb, D. O. (1949). The Organization of Behavior: A Neuropsychological Theory. New York, NY: Wiley and Sons.
Iacoboni, M., Molnar-Szakacs, I., Gallese, V., Buccino, G., & Rizzolatti, G. (2005). Grasping the intentions of other’s with one’s own mirror neuron system. PLOS Biology, 3: 1-15.
Kandel, E. R. (1998). A new intellectual framework for psychiatry. American Journal of Psychiatry, 155, 457-469.
Kandel, E. R. (2001). The molecular biology of memory storage: A dialogue between genes and synapses. Science, 294, 1030-1038. doi:http://dx.doi.org/10.1126/science.1067020
Kandel, E. R. (2005). Psychiatry, psychoanalysis and the new biology of mind. Washington, DC: American Psychiatric Publishing.
Kandel, E. R. (2006). In search of memory: The emergence of a new science of mind. New York, NY: W. W. Norton.
Kandel, E. R., Schwartz, J. H., & Jessell, T. M. (Eds.). (2013). Principles of neural science (5th ed.). New York, NY: McGraw-Hill.
Kilner, J. M., Friston, K. J., Frith, C. D. (2007). Predictive coding: An account of the mirror neuron system. Cognitive Process, 8(3), 159-166. doi: 10.1007/s10339-007-0170-2
LeDoux, J. (2003). Synaptic self: How our brains become who we are. New York, NY: Penguin.
Oberman, L. M., & Ramachandran, V. S. (2008). Reflections on the mirror neuron system: Their evolutionary functions beyond motor representation. In J. A. Pineda (Ed.), Mirror neuron systems: The role of mirroring processes in social cognition (pp. 39–62). New York, NY: Humana Press.
Rizolatti, G., & Craighero, L. (2004). The mirror-neuron system. Annual Review of Neuroscience, 27, 169–192. doi: 10.1146/annurev.neuro.27.070203.144230
Rossouw, P. J. (2011, October). The treatment of anxiety and depression: Medication or psychotherapy? Neuropsychotherapy News, 8, 2-6. Retrieved from http://mediros.com.au/wp-content/uploads/2012/11/NPTIG-Newsletter-8.pdf
Rossouw, P. J. (2012, September/October). Engaging in therapy and history taking: Right brain to right brain communication. Neuropsychotherapy in Australia, 17, 3–7. Retrieved from http://mediros.com.au/wp-content/uploads/2012/11/NPTIG-e-journal-17.pdf
Rossouw, P. J. (2013a, January/February). The end of the medical model? Recent findings in neuroscience regarding antidepressant medication: Implications for Neuropsychotherapy. Neuropsychotherapy in Australia, 19, 3-10. Retrieved from http://mediros.com.au/wp-content/uploads/2013/01/Neuropsychotherapy-in-Australia-E-Journal-Edition-19.pdf
Rossouw, P. J. (2013b). The neuroscience of talking therapies: Implications for therapeutic practice. Australian Journal of Counselling Psychology, 13(1), 40–49.
Rossouw, P. J. (2013c, July/August). The diagnosis of mental disorders—the DSM-5 and neuroscience: Highlights and controversy. Neuropsychotherapy in Australia, 22, 4–7. Retrieved from http://www.mediros.com.au/wp-content/uploads/2013/08/E-Journal-Neuropsychotherapy-in-Australia-Edition-22.pdf
Schore, A. (2012). The science of the art of psychotherapy. New York, NY: W. W. Norton.
Shen, S., Battersby, S., Weaver, M., Clark, E., Stephens, K., & Harmar, A. J. (2000). Refined mapping of the human serotonin transporter (SLC6A4) gene within 17q11 adjacent to the CPD and NF1 genes. European Journal of Human Genetics, 8: 75–78.
Siegel, D. J. (2010). The mindful therapist: A clinician’s guide to mindsight and neural integration. New York, NY: W. W. Norton.
Siegel, D. J. (2012). The developing mind: How relationships and the brain interact to shape who we are (2nd ed.). New York, NY: Guilford Press.
Springer, S. P., & Deutsch, G. (1999). Left brain right brain: Perspectives from cognitive neuroscience. New York, NY: W. H. Freedman.